(Reuters) -Pfizer Inc plans to tap the mRNA technology to make new vaccines for other viruses following the success of its COVID-19 shot, which was developed jointly with German partner BioNTech SE, the Wall Street Journal reported on Tuesday. The drugmaker said it was ready to pursue mRNA on its own following its experience in the past year working on the COVID-19 vaccine, the WSJ reported, citing an interview with Pfizer Chief Executive Officer Albert Bourla. It did not, however, disclose any details about the viruses it was targeting.
The success of the technology is prompting drug developers to consider its use in other areas of medicine beyond vaccines, attracting billions of dollars in investment.
Pfizer and BioNTech did not immediately respond to Reuters requests for comment. Pfizer/BioNTech and Moderna’s COVID-19 vaccines, authorized for emergency use in the United States, use mRNA technology. Nick Note: A star is born and not some actor liar, music whore, clown, ball playing neanderthal gorilla… But the real heroes are people vewith brains curing disease, making global communications systems, engineering food systems,,,,, and providing energy for the world. Unfortunately like the birds they are attracted to some fool singing a song… some ape-man with big mussels or a bad boy criminal who makes their nipples hard. While geniuses are called nerds and shunned. So when they come back to you broke and with a couple kids remember its their bad decisions that put them in the sorry ass life they really deser..